CHRISTOPHER KALLUS,MARKK BROENSTRUP,ANDREAS EVERS,ANJA GLOBISCH,HERMAN SCHREUDER,MICHAEL WAGNER
申请号：
HN2010002558
公开号：
HN2010002558A
申请日:
2010.12.03
申请国别(地区):
HN
年份:
2012
代理人:
摘要：
The present Invention relates to compounds of formula (i) which are inhibitors of Thrombin activatable fibrinolysis by activated. The compounds of formula I are suitable for the manufacture of medicaments for the prophylaxis and Therapy of secondary prevention, one or more Disorders associated with hypercoagulability and thrombosis, fibrotic changes.LA PRESENTE INVENCION SE REFIERE A COMPUESTOS DE FORMULA (I) QUE SON INHIBIDORES DE LA FIBRINOLISIS ACTIVABLE POR TROMBINA ACTIVADA. LOS COMPUESTOS DE LA FORMULA I SON ADECUADOS PARA LA FABRICACION DE MEDICAMENTOS PARA LA PROFILAXIS, PREVENCION SECUNDARIA Y TERAPIA DE UNO O MAS TRASTORNOS ASOCIADOS CON TROMBOSIS, HIPERCOAGULABILIDAD O CAMBIOS FIBROTICOS.
